Form 8-K - Current report:
SEC Accession No. 0001193125-21-077841
Filing Date
2021-03-11
Accepted
2021-03-11 16:23:07
Documents
13
Period of Report
2021-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d113234d8k.htm   iXBRL 8-K 25588
2 EX-99.1 d113234dex991.htm EX-99.1 54730
  Complete submission text file 0001193125-21-077841.txt   215589

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acet-20210311.xsd EX-101.SCH 3073
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acet-20210311_lab.xml EX-101.LAB 18888
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acet-20210311_pre.xml EX-101.PRE 11862
6 EXTRACTED XBRL INSTANCE DOCUMENT d113234d8k_htm.xml XML 3468
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 21733607
SIC: 2834 Pharmaceutical Preparations